Haemophilus ducreyi is the causative agent of chancroid, a sexually transmitted genital ulcerative disease. Chancroid is common in the developing world and occurs sporadically in North American. In addition to the rabidity due to chancroid, genital ulcers are thought to facilitate the heterosexual transmission of the HIV virus. The molecular mechanism(s) responsible for formation of the chancroid ulcer are not known. We have identified a toxin which has hemolytic activity directed against horse erythrocytes. We hypothesize that this hemolysin has cytotoxic activity directed against human cells and plays a direct role in the formation of the chancroid ulcer. We will employe genetic an biochemical approaches to characterize this toxin. The structural gene(s) will be cloned, sequenced and expressed in E> coli. Mutants of H. ducreyi deficient in production of the toxin will be constructed by allele replacement and tested for virulence in in vitro models, a rabbit model, and in human challenge studies. These studies will broaden our outstanding of the hemolysin by providing data on in vivo targets of this activity, and by providing data on the role of the hemolysin in the pathogenesis of the human chancroid lesion.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI034967-01
Application #
2070274
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1993-12-01
Project End
1994-10-30
Budget Start
1993-12-01
Budget End
1994-10-30
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Washington University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Post, Deborah M B; Munson Jr, Robert S; Baker, Beth et al. (2007) Identification of genes involved in the expression of atypical lipooligosaccharide structures from a second class of Haemophilus ducreyi. Infect Immun 75:113-21
Young, R S; Fortney, K R; Gelfanova, V et al. (2001) Expression of cytolethal distending toxin and hemolysin is not required for pustule formation by Haemophilus ducreyi in human volunteers. Infect Immun 69:1938-42
Bozue, J A; Tullius, M V; Wang, J et al. (1999) Haemophilus ducreyi produces a novel sialyltransferase. Identification of the sialyltransferase gene and construction of mutants deficient in the production of the sialic acid-containing glycoform of the lipooligosaccharide. J Biol Chem 274:4106-14
Palmer, K L; Thornton, A C; Fortney, K R et al. (1998) Evaluation of an isogenic hemolysin-deficient mutant in the human model of Haemophilus ducreyi infection. J Infect Dis 178:191-9
Bozue, J A; Tarantino, L; Munson Jr, R S (1998) Facile construction of mutations in Haemophilus ducreyi using lacZ as a counter-selectable marker. FEMS Microbiol Lett 164:269-73
Palmer, K L; Goldman, W E; Munson Jr, R S (1996) An isogenic haemolysin-deficient mutant of Haemophilus ducreyi lacks the ability to produce cytopathic effects on human foreskin fibroblasts. Mol Microbiol 21:13-9
Tullius, M V; Munson Jr, R S; Wang, J et al. (1996) Purification, cloning, and expression of a cytidine 5'-monophosphate N-acetylneuraminic acid synthetase from Haemophilus ducreyi. J Biol Chem 271:15373-80
Palmer, K L; Munson Jr, R S (1995) Cloning and characterization of the genes encoding the hemolysin of Haemophilus ducreyi. Mol Microbiol 18:821-30
Palmer, K L; Grass, S; Munson Jr, R S (1994) Identification of a hemolytic activity elaborated by Haemophilus ducreyi. Infect Immun 62:3041-3